DUBLIN–(BUSINESS WIRE)–The “Global Transfection Technologies Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
The transfection technologies market is poised to grow by $526.14 mn during 2022-2026, accelerating at a CAGR of 9.05% during the forecast period. The report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, availability of innovative products, and high demand for biopharmaceuticals.
The transfection technologies market analysis includes the end-user segment and geographic landscape.
The transfection technologies market is segmented as below:
By End-user
- Pharmaceutical and biotechnology companies
- Contract research organizations
- Academic and research institutes
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
This study identifies the increased use of dual-reporter assays and co-transfection experiments as one of the prime reasons driving the transfection technologies market growth during the next few years. Also, optimization of transfection efficiency and growth in initiatives for molecular research and related activities will lead to sizable demand in the market.
The report on the transfection technologies market covers the following areas:
- Transfection technologies market sizing
- Transfection technologies market forecast
- Transfection technologies market industry analysis
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Companies Mentioned
- Altogen Biosystems
- Bio Rad Laboratories Inc.
- Biontex Laboratories GmbH
- Boca Scientific Inc.
- F. Hoffmann La Roche Ltd.
- GENLANTIS
- Inovio Pharmaceuticals Inc.
- Lonza Group Ltd.
- MaxCyte Inc.
- Merck KGaA
- Mirus Bio LLC
- OZ Biosciences
- Polyplus Transfection S.A
- Promega Corp.
- PromoCell GmbH
- QIAGEN NV
- SignaGen Laboratories
- Takara Holdings Inc
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/790j9l
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900